Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis B Virus Vaccines
Studies from Nanjing University provide new data on hepatitis B virus vaccines
December 31st, 2008
Investigators publish new data in the report 'Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants.' According to recent research from Nanjing, People's Republic of China, "Transplacentally acquired maternal antibodies in infants may inhibit active immune responses to vaccines. In this study, we compared the immunogenicity of the recombinant hepatitis B vaccine, which was intramuscularly injected at 0, 1, and 6 months of age, in 71 infants born to mothers with positive or negative antibody against hepatitis B surface antigen (anti-HBs)." "Forty-one infants born to anti-HBs positive mothers were...
Source: Vaccine Weekly (2008-12-31)
|
